19 February 2020 - Deborah Wilkes
Archived
Alcon is launching two OTC versions of its Pataday (olopatadine hydrochloride) eye allergy drops in the US after the US Food and Drug Administration (FDA) approved a switch from prescription-to-OTC status for the medicines.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.